Full Text
P30 Potential Impacts of the New MHRA Policy for Biosimilar Approval for the Industry and Patients

Abstract

Authors

A Ribeiro A Walker K Walsh

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×